US Patent Issued to COGNIZANCE BIOMARKERS on Dec. 16 for "Biomarkers and methods for evaluation and treatment of epileptic vs non-epileptic seizures / no seizures / psychogenic non-epileptic seizures" (Kansas Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,498,384, issued on Dec. 16, was assigned to COGNIZANCE BIOMARKERS INC. (Miami).

"Biomarkers and methods for evaluation and treatment of epileptic vs non-epileptic seizures / no seizures / psychogenic non-epileptic seizures" was invented by Todd Wallach (Overland Park, Kan.), John Gledhill (Overland Park, Kan.), Richard St. Clair (Overland Park, Kan.) and Elizabeth Brand (Overland Park, Kan.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Epileptic seizures, NES, NS, PNES or NEE are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensiv...